News | April 19, 2022
PM Narendra Modi lays down five goals for new WHO Global Centre
Jamnagar’s contributions towards wellness will get a global identity with WHO’s Global Centre for Traditional Medicine
Jamnagar’s contributions towards wellness will get a global identity with WHO’s Global Centre for Traditional Medicine
By strengthening the company's fibrotic disease development pipeline, Bridge will enhance its strategic focus on the development of comprehensive treatment solutions for idiopathic pulmonary fibrosis (IPF)
The data driven fertility company helps increase the success rate of fertility treatments
The facility will support clinical development by securing supply that will address the critical demand in the gene therapy and vaccine markets
These melas serve as platforms to attract thousands of people to avail quality healthcare services along with essential medicines and diagnostic services
This product will be manufactured at Lupin’s Nagpur facility in India
The drug will be manufactured at the group's injectables manufacturing facility at Jarod, Gujarat
The HD-550 endoscopy system has been available outside of the USA since 2019
Marks the second of three biosimilars Amneal expects to receive U.S. approval for in 2022
Momelotinib complements GSK’s existing expertise in haematology, with Sierra Oncology anticipating US regulatory submission in Q2 this year and EU submission in the second half of 2022
Subscribe To Our Newsletter & Stay Updated
